From: HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy
ID
IHC (HER2)
HER2/CEP 17 Ratio
IHC/FISH concordance
VB1
0
0.9
VB2
0.8
VB3
VB4
1
1.2
VB5
VB6
1.0
J1
3
3.2
J2
J3
J4
1.1
J5
J6
J7
2.4
Discordant
J8
2
3.1
J9
1.3
J10